Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

NINJA is comparing two emerging, potentially practice-changing radiotherapy schedules for Prostate Cancer, delivered in as little as 5 outpatient visits. Leveraging state-of-the-art technology we aim to use existing equipment throughout Australia and NZ to achieve high rates of disease control while also improving patient safety and convenience.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Participating Centres

Accrual Target

472

Current Accrual

Trial Chairperson

Prof Jarad Martin, Calvary Mater Hospital, NSW, Australia
Dr Mark Sidhom, Liverpool Hospital, NSW, Australia

Trial Contact

ninjatrial@calvarymater.org.au

Clinical Trial Registration

Related Post

August 2, 2022

Celebrating and bringing radiation medicine research to the forefront at our 2022 ASM

After a hiatus from in-person events due to COVID-19

February 28, 2022

Cancer trial participant hoping to help

The RAVES trial treating prostate cancer Participating in a